GlobeNewswire by notified

Ensurge starts manufacturing scale-up and commercialization of the world’s first high energy density rechargeable solid-state microbatteries

Share

SAN JOSE, Calif., May 22, 2023 - Ensurge Micropower (OSE: ENSU, and OTCIQ: ENMPY), a leading provider of solid-state lithium microbatteries for a new generation of wearables, hearables and IoT devices, today announced it is reliably producing packaged lithium solid-state microbatteries with high performance and improved manufacturing flow. In addition to this progress, Ensurge has started producing sample volumes of high capacity multi-layer solid-state lithium microbatteriesusing its innovative and unique architecture based on a 10-micron stainless steel substrate. Achieving these industry-first milestones is a major step toward bringing Ensurge's  solid-state microbattery products into volume production, now projected for the second half of the year.

“These two milestones are extremely significant for Ensurge as it prepares to scale production for these market-changing solid-state lithium microbatteries.  Our batteries will revolutionize the way next generation products are designed to enable enhanced capabilities and performance,” said Mark Newman, Ensurge Chief Executive Officer. “The Ensurge technical and operations teams have done a phenomenal job in making substantial progress over the last six (6) months to realize the world’s first high energy density microbatteries with capacities in the 1 to 100 milliampere-hour range (mAh).”

Ensurge’s solid-state lithium microbatteries provide Volumetric Energy Density (VED) of 650 to 750 Watt-hours per liter (Wh/L) that is as much as three times that of similar capacity Lithium-ion (Li-ion) microbatteries and up to ten times that of competing solid-state microbatteries. This VED breakthrough enables Ensurge microbatteries to pack more capacity in a small form factor that is also customizable to suit the shape of the end-product. Beyond their VED advancements, these solid-state lithium microbatteries also provide other benefits including charging to 80% battery capacity in 20 minutes compared to Li-ion microbatteries, which need up to 2 hours to be recharged. Also, Ensurge microbatteries support higher discharge pulses of at least 5C, enabling them to support many wireless communication chipsets or other current load transients as hearable and wearable users demand improved connectivity. Additionally, the ability for the microbattieries to be assembled using a standard Surface Mount Technology (SMT) process reduces manufacturing costs while increasing production output. 

Ensurge is simultaneously preparing to scale production of a customized version of its microbattery that it has developed for an innovator in the digital health market. This customer placed a 150,000-unit order for the product in December 2022. 

Over the past 10 months, Ensurge has made steady progress toward bringing its microbattery to market, including shipping unit-cell samples and then packaged microbattery samples to multiple prospective customers and strategic partners. Through these development stages, the company has validated key elements of its solid-state lithium microbattery chemistry and packaging that will enable hearable and wearable suppliers to create products with features that cannot be offered using alternative battery technology.

For more information about Ensurge's microbattery technology visit the company's website at www.ensurge.com

About Ensurge Micropower

Ensurge is Energizing Innovation™ with the first ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100 milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond. The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company's state-of-the-art manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of Ensurge technology to established and expanding markets.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Contact 

Mark Newman - Chief Executive Officer 
E-mail: mark.newman@ensurge.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye